Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro

Background Pentoxifylline (PTX), a methylxanthine derivate with immunomodulating properties, has been used as adjunctive treatment in severe neonatal sepsis. The aim of the study was to investigate the anti-inflammatory effects of PTX on Lipopolysaccharides (LPS)-stimulated monocytes of preterm neon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric research 2017-08, Vol.82 (2), p.215-225
Hauptverfasser: Schüller, Simone S, Wisgrill, Lukas, Herndl, Elisabeth, Spittler, Andreas, Förster-Waldl, Elisabeth, Sadeghi, Kambis, Kramer, Boris W, Berger, Angelika
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 225
container_issue 2
container_start_page 215
container_title Pediatric research
container_volume 82
creator Schüller, Simone S
Wisgrill, Lukas
Herndl, Elisabeth
Spittler, Andreas
Förster-Waldl, Elisabeth
Sadeghi, Kambis
Kramer, Boris W
Berger, Angelika
description Background Pentoxifylline (PTX), a methylxanthine derivate with immunomodulating properties, has been used as adjunctive treatment in severe neonatal sepsis. The aim of the study was to investigate the anti-inflammatory effects of PTX on Lipopolysaccharides (LPS)-stimulated monocytes of preterm neonates in vitro compared with monocytes of term infants and adult controls. Methods Whole cord blood samples and control adult blood samples were incubated with LPS and PTX. The expression of surface markers, phagocytosis, cytokine secretion, and Toll-like receptor (TLR)4 signaling of monocytes were assessed by flow cytometry. Changes of TLR4-messenger RNA (mRNA) levels were confirmed by reverse-transcriptase PCR. Results The expression of CD14, CD11b, CD64, CD71, and CD80 was downregulated by PTX in a dose-dependent manner; the greatest effect was observed on CD14 and CD11b in preterm infants. PTX markedly downregulated LPS-induced tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels in all age groups. Early IL-10 production was significantly downregulated by PTX in term and preterm neonates, while remaining unchanged in adults. Moreover, PTX downregulated TLR4 expression of monocytes on cellular and mRNA level, decreased signaling, and suppressed phagocytosis. Conclusion PTX downregulated TLR4 expression and signaling, thereby leading to strong anti-inflammatory properties in monocytes. Age-dependent differences were identified for CD14 and CD11b expression and IL-10 production.
doi_str_mv 10.1038/pr.2017.41
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1877525769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1877525769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-d9c7155b3e2af3981a3f39e9db4f4e1bb6272f7051f70058cb498c0d2e20df883</originalsourceid><addsrcrecordid>eNpl0E2LFDEQBuAgLu64evEHSIMXUXpM5WOSHJfFj4UBF9RzSHdXNEt30ibd4vx7M8wqsntJkdTDW6EIeQF0C5Trd3PeMgpqK-AR2YDktKVCqMdkQymHlhujz8nTUm4pBSG1eELOmWZag4QNsTcYl_Q7-MM4hojNlIZ1dAuWZn_zpQ1xWHscmh-HGXOIfnTT5JaQYhNipTH1hyNNvpkzLpin-u5dXMqx_yssOT0jZ96NBZ_f1Qvy7cP7r1ef2v3nj9dXl_u251ot7WB6BVJ2HJnz3GhwvBY0Qye8QOi6HVPMKyqhHlTqvhNG93RgyOjgteYX5PUpd87p54plsVMoPY6ji5jWYkErJZlUO1Ppq3v0Nq051t9ZMExJqZXZVfXmpPqcSsno7ZzD5PLBArXHtde7Pa7dCqj45V3k2k04_KN_91zB2xMotRW_Y_5v5sO4P1VwjHs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1927558796</pqid></control><display><type>article</type><title>Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Schüller, Simone S ; Wisgrill, Lukas ; Herndl, Elisabeth ; Spittler, Andreas ; Förster-Waldl, Elisabeth ; Sadeghi, Kambis ; Kramer, Boris W ; Berger, Angelika</creator><creatorcontrib>Schüller, Simone S ; Wisgrill, Lukas ; Herndl, Elisabeth ; Spittler, Andreas ; Förster-Waldl, Elisabeth ; Sadeghi, Kambis ; Kramer, Boris W ; Berger, Angelika</creatorcontrib><description>Background Pentoxifylline (PTX), a methylxanthine derivate with immunomodulating properties, has been used as adjunctive treatment in severe neonatal sepsis. The aim of the study was to investigate the anti-inflammatory effects of PTX on Lipopolysaccharides (LPS)-stimulated monocytes of preterm neonates in vitro compared with monocytes of term infants and adult controls. Methods Whole cord blood samples and control adult blood samples were incubated with LPS and PTX. The expression of surface markers, phagocytosis, cytokine secretion, and Toll-like receptor (TLR)4 signaling of monocytes were assessed by flow cytometry. Changes of TLR4-messenger RNA (mRNA) levels were confirmed by reverse-transcriptase PCR. Results The expression of CD14, CD11b, CD64, CD71, and CD80 was downregulated by PTX in a dose-dependent manner; the greatest effect was observed on CD14 and CD11b in preterm infants. PTX markedly downregulated LPS-induced tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels in all age groups. Early IL-10 production was significantly downregulated by PTX in term and preterm neonates, while remaining unchanged in adults. Moreover, PTX downregulated TLR4 expression of monocytes on cellular and mRNA level, decreased signaling, and suppressed phagocytosis. Conclusion PTX downregulated TLR4 expression and signaling, thereby leading to strong anti-inflammatory properties in monocytes. Age-dependent differences were identified for CD14 and CD11b expression and IL-10 production.</description><identifier>ISSN: 0031-3998</identifier><identifier>EISSN: 1530-0447</identifier><identifier>DOI: 10.1038/pr.2017.41</identifier><identifier>PMID: 28288151</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/92/436/108 ; 692/420/256 ; 692/700/1720/3185 ; 692/700/565/251 ; Adult ; Antigens, CD - metabolism ; Dose-Response Relationship, Drug ; Humans ; In Vitro Techniques ; Infant, Newborn ; Infant, Premature ; Inflammation ; Inflammation - chemically induced ; Inflammation - prevention &amp; control ; Lipopolysaccharides - adverse effects ; Medicine ; Medicine &amp; Public Health ; Monocytes - metabolism ; Neonatal care ; Newborn babies ; Pediatric Surgery ; Pediatrics ; Pentoxifylline - pharmacology ; Phagocytosis - drug effects ; Premature birth ; Sepsis ; translational-investigation</subject><ispartof>Pediatric research, 2017-08, Vol.82 (2), p.215-225</ispartof><rights>International Pediatric Research Foundation, Inc. 2017</rights><rights>Copyright Nature Publishing Group Aug 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-d9c7155b3e2af3981a3f39e9db4f4e1bb6272f7051f70058cb498c0d2e20df883</citedby><cites>FETCH-LOGICAL-c387t-d9c7155b3e2af3981a3f39e9db4f4e1bb6272f7051f70058cb498c0d2e20df883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28288151$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schüller, Simone S</creatorcontrib><creatorcontrib>Wisgrill, Lukas</creatorcontrib><creatorcontrib>Herndl, Elisabeth</creatorcontrib><creatorcontrib>Spittler, Andreas</creatorcontrib><creatorcontrib>Förster-Waldl, Elisabeth</creatorcontrib><creatorcontrib>Sadeghi, Kambis</creatorcontrib><creatorcontrib>Kramer, Boris W</creatorcontrib><creatorcontrib>Berger, Angelika</creatorcontrib><title>Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro</title><title>Pediatric research</title><addtitle>Pediatr Res</addtitle><addtitle>Pediatr Res</addtitle><description>Background Pentoxifylline (PTX), a methylxanthine derivate with immunomodulating properties, has been used as adjunctive treatment in severe neonatal sepsis. The aim of the study was to investigate the anti-inflammatory effects of PTX on Lipopolysaccharides (LPS)-stimulated monocytes of preterm neonates in vitro compared with monocytes of term infants and adult controls. Methods Whole cord blood samples and control adult blood samples were incubated with LPS and PTX. The expression of surface markers, phagocytosis, cytokine secretion, and Toll-like receptor (TLR)4 signaling of monocytes were assessed by flow cytometry. Changes of TLR4-messenger RNA (mRNA) levels were confirmed by reverse-transcriptase PCR. Results The expression of CD14, CD11b, CD64, CD71, and CD80 was downregulated by PTX in a dose-dependent manner; the greatest effect was observed on CD14 and CD11b in preterm infants. PTX markedly downregulated LPS-induced tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels in all age groups. Early IL-10 production was significantly downregulated by PTX in term and preterm neonates, while remaining unchanged in adults. Moreover, PTX downregulated TLR4 expression of monocytes on cellular and mRNA level, decreased signaling, and suppressed phagocytosis. Conclusion PTX downregulated TLR4 expression and signaling, thereby leading to strong anti-inflammatory properties in monocytes. Age-dependent differences were identified for CD14 and CD11b expression and IL-10 production.</description><subject>631/92/436/108</subject><subject>692/420/256</subject><subject>692/700/1720/3185</subject><subject>692/700/565/251</subject><subject>Adult</subject><subject>Antigens, CD - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Inflammation</subject><subject>Inflammation - chemically induced</subject><subject>Inflammation - prevention &amp; control</subject><subject>Lipopolysaccharides - adverse effects</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Monocytes - metabolism</subject><subject>Neonatal care</subject><subject>Newborn babies</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Pentoxifylline - pharmacology</subject><subject>Phagocytosis - drug effects</subject><subject>Premature birth</subject><subject>Sepsis</subject><subject>translational-investigation</subject><issn>0031-3998</issn><issn>1530-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpl0E2LFDEQBuAgLu64evEHSIMXUXpM5WOSHJfFj4UBF9RzSHdXNEt30ibd4vx7M8wqsntJkdTDW6EIeQF0C5Trd3PeMgpqK-AR2YDktKVCqMdkQymHlhujz8nTUm4pBSG1eELOmWZag4QNsTcYl_Q7-MM4hojNlIZ1dAuWZn_zpQ1xWHscmh-HGXOIfnTT5JaQYhNipTH1hyNNvpkzLpin-u5dXMqx_yssOT0jZ96NBZ_f1Qvy7cP7r1ef2v3nj9dXl_u251ot7WB6BVJ2HJnz3GhwvBY0Qye8QOi6HVPMKyqhHlTqvhNG93RgyOjgteYX5PUpd87p54plsVMoPY6ji5jWYkErJZlUO1Ppq3v0Nq051t9ZMExJqZXZVfXmpPqcSsno7ZzD5PLBArXHtde7Pa7dCqj45V3k2k04_KN_91zB2xMotRW_Y_5v5sO4P1VwjHs</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Schüller, Simone S</creator><creator>Wisgrill, Lukas</creator><creator>Herndl, Elisabeth</creator><creator>Spittler, Andreas</creator><creator>Förster-Waldl, Elisabeth</creator><creator>Sadeghi, Kambis</creator><creator>Kramer, Boris W</creator><creator>Berger, Angelika</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20170801</creationdate><title>Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro</title><author>Schüller, Simone S ; Wisgrill, Lukas ; Herndl, Elisabeth ; Spittler, Andreas ; Förster-Waldl, Elisabeth ; Sadeghi, Kambis ; Kramer, Boris W ; Berger, Angelika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-d9c7155b3e2af3981a3f39e9db4f4e1bb6272f7051f70058cb498c0d2e20df883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>631/92/436/108</topic><topic>692/420/256</topic><topic>692/700/1720/3185</topic><topic>692/700/565/251</topic><topic>Adult</topic><topic>Antigens, CD - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Inflammation</topic><topic>Inflammation - chemically induced</topic><topic>Inflammation - prevention &amp; control</topic><topic>Lipopolysaccharides - adverse effects</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Monocytes - metabolism</topic><topic>Neonatal care</topic><topic>Newborn babies</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Pentoxifylline - pharmacology</topic><topic>Phagocytosis - drug effects</topic><topic>Premature birth</topic><topic>Sepsis</topic><topic>translational-investigation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schüller, Simone S</creatorcontrib><creatorcontrib>Wisgrill, Lukas</creatorcontrib><creatorcontrib>Herndl, Elisabeth</creatorcontrib><creatorcontrib>Spittler, Andreas</creatorcontrib><creatorcontrib>Förster-Waldl, Elisabeth</creatorcontrib><creatorcontrib>Sadeghi, Kambis</creatorcontrib><creatorcontrib>Kramer, Boris W</creatorcontrib><creatorcontrib>Berger, Angelika</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schüller, Simone S</au><au>Wisgrill, Lukas</au><au>Herndl, Elisabeth</au><au>Spittler, Andreas</au><au>Förster-Waldl, Elisabeth</au><au>Sadeghi, Kambis</au><au>Kramer, Boris W</au><au>Berger, Angelika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro</atitle><jtitle>Pediatric research</jtitle><stitle>Pediatr Res</stitle><addtitle>Pediatr Res</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>82</volume><issue>2</issue><spage>215</spage><epage>225</epage><pages>215-225</pages><issn>0031-3998</issn><eissn>1530-0447</eissn><abstract>Background Pentoxifylline (PTX), a methylxanthine derivate with immunomodulating properties, has been used as adjunctive treatment in severe neonatal sepsis. The aim of the study was to investigate the anti-inflammatory effects of PTX on Lipopolysaccharides (LPS)-stimulated monocytes of preterm neonates in vitro compared with monocytes of term infants and adult controls. Methods Whole cord blood samples and control adult blood samples were incubated with LPS and PTX. The expression of surface markers, phagocytosis, cytokine secretion, and Toll-like receptor (TLR)4 signaling of monocytes were assessed by flow cytometry. Changes of TLR4-messenger RNA (mRNA) levels were confirmed by reverse-transcriptase PCR. Results The expression of CD14, CD11b, CD64, CD71, and CD80 was downregulated by PTX in a dose-dependent manner; the greatest effect was observed on CD14 and CD11b in preterm infants. PTX markedly downregulated LPS-induced tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels in all age groups. Early IL-10 production was significantly downregulated by PTX in term and preterm neonates, while remaining unchanged in adults. Moreover, PTX downregulated TLR4 expression of monocytes on cellular and mRNA level, decreased signaling, and suppressed phagocytosis. Conclusion PTX downregulated TLR4 expression and signaling, thereby leading to strong anti-inflammatory properties in monocytes. Age-dependent differences were identified for CD14 and CD11b expression and IL-10 production.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>28288151</pmid><doi>10.1038/pr.2017.41</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0031-3998
ispartof Pediatric research, 2017-08, Vol.82 (2), p.215-225
issn 0031-3998
1530-0447
language eng
recordid cdi_proquest_miscellaneous_1877525769
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects 631/92/436/108
692/420/256
692/700/1720/3185
692/700/565/251
Adult
Antigens, CD - metabolism
Dose-Response Relationship, Drug
Humans
In Vitro Techniques
Infant, Newborn
Infant, Premature
Inflammation
Inflammation - chemically induced
Inflammation - prevention & control
Lipopolysaccharides - adverse effects
Medicine
Medicine & Public Health
Monocytes - metabolism
Neonatal care
Newborn babies
Pediatric Surgery
Pediatrics
Pentoxifylline - pharmacology
Phagocytosis - drug effects
Premature birth
Sepsis
translational-investigation
title Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A46%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pentoxifylline%20modulates%20LPS-induced%20hyperinflammation%20in%20monocytes%20of%20preterm%20infants%20in%20vitro&rft.jtitle=Pediatric%20research&rft.au=Sch%C3%BCller,%20Simone%20S&rft.date=2017-08-01&rft.volume=82&rft.issue=2&rft.spage=215&rft.epage=225&rft.pages=215-225&rft.issn=0031-3998&rft.eissn=1530-0447&rft_id=info:doi/10.1038/pr.2017.41&rft_dat=%3Cproquest_cross%3E1877525769%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1927558796&rft_id=info:pmid/28288151&rfr_iscdi=true